Early safety study of experimental drug LY3463251 halted
NCT ID NCT03764774
First seen Nov 05, 2025 · Last updated May 24, 2026 · Updated 24 times
Summary
This early-stage study aimed to check the safety and side effects of a new drug called LY3463251 in healthy and overweight adults. Participants received either the drug or a placebo under the skin. The study was stopped early, and no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Covance Clinical Research Inc
Daytona Beach, Florida, 32117, United States
Conditions
Explore the condition pages connected to this study.